ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2019

Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.

Alexey M Petrov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.